Manjula Kurella Tamura, Kristine Yaffe Kidney International

Slides:

Advertisements

Similar presentations

A.M. Thompson, T.G. Pickering Kidney International

Advertisements

Treatment of acute renal failure

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Manjula Kurella Tamura,

Intensive hemodialysis—keeping the faith

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Manjula Kurella Tamura,

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

C-reactive protein and dialysis access

Intensive hemodialysis—keeping the faith

Prehypertension and chronic kidney disease: the ox or the plow?

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Recognition for Conservative Care in Kidney Failure

C-reactive protein and dialysis access

John P. Middleton, Patrick H. Pun Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Francesco Paolo Schena Kidney International

Manjula Kurella, Jennifer Luan, Kristine Yaffe, Glenn M. Chertow

Volume 77, Issue 8, Pages (April 2010)

The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli Richard J. Glassock, Andrew D. Rule Kidney.

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 77, Issue 1, Pages 5-6 (January 2010)

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Treatment of acute renal failure

Volume 75, Issue 1, Pages (January 2009)

U-shaped effect of eGFR and mortality

Volume 70, Issue 12, Pages (December 2006)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Volume 75, Issue 1, Pages (January 2009)

Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation? Pantelis A. Sarafidis, Luis.

Volume 76, Issue 3, Pages (August 2009)

Drug Dose Adjustments in Patients With Renal Impairment

Does reducing salt intake increase cardiovascular mortality?

Elevated risk of stroke among patients with end-stage renal disease

Methods for guideline development

Racial disparities in access to transplantation: a tough nut to crack

Volume 76, Issue 8, Pages (October 2009)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 81, Issue 9, Pages (May 2012)

Volume 80, Issue 3, Pages (August 2011)

Prehypertension: is it relevant for nephrologists?

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial

Peritoneal dialysis in Mexico

Volume 76, Issue 6, Pages (September 2009)

The Iranian model of living renal transplantation

Blood lead and chronic kidney disease in the general United States population: Results from NHANES III Paul Muntner, Jiang He, Suma Vupputuri, Josef.

Volume 80, Issue 10, Pages (November 2011)

In the Literature: Cognitive Impairment in Hemodialysis Patients

ANCA comes of age—but with caveats

Volume 75, Issue 7, Pages (April 2009)

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 88, Issue 5, Pages (November 2015)

Antioxidant therapy in hemodialysis patients: a systematic review

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies Manjula Kurella Tamura, Kristine Yaffe Kidney International Volume 79, Issue 1, Pages 14-22 (January 2011) DOI: 10.1038/ki.2010.336 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Prevalence of cognitive impairment among patients with end-stage renal disease (ESRD) by age group. Note: The clinical trial sample consisted of 383 hemodialysis patients participating in the Frequent Hemodialysis Network Trials. Cognitive impairment was defined as a Modified Mini-Mental State Exam score <80 (ref. 15). The community sample consisted of 374 hemodialysis patients in Minnesota. Cognitive impairment was defined according to performance on a neuropsychological battery.11 Kidney International 2011 79, 14-22DOI: (10.1038/ki.2010.336) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Prevalence of cognitive impairment among 23405 US adults, according to estimated glomerular filtration rate (GFR). Data are adapted from Kurella Tamura et al.30 Kidney International 2011 79, 14-22DOI: (10.1038/ki.2010.336) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Proposed mechanisms of dementia in end-stage renal disease (ESRD). Kidney International 2011 79, 14-22DOI: (10.1038/ki.2010.336) Copyright © 2011 International Society of Nephrology Terms and Conditions